Loaded up31 Jul 2019 11:44
Quote from the other chat site "agreed....phase III is non-inferiority....ie. it has to be NO WORSE than is currently available....which is a forty year old tech, radiation based so can't be used too often, with blurry 2D images and no lung function measurements available.. Polarean images are 3D, repeatable because no radiation is involved and show not only lung function and problem areas but the interactions within the pulmonary system ie. gas exchange between lungs and blood..... Polarean are already working on their New Drug Application for the FDA and they are being encouraged to act quickly because there are already drug companies who wish to use this new tech to better test their own new drugs on lung disease and function... They have also said that they are investigating whether this process can be used for cardiac diagnosis as well... There are 35,000 MRI machines around the world and their use has become commonplace in most areas of medicine....except for lung....which, until now, has been notoriously difficult to image and investigate....what hospital radiology department won't want to have this tech available! 25 machines already sold and in use on a trial basis....100 machines operating clinically after approvals together with maintenance, software updates and sale of disposable equipment needed to run them could/would justify a £200m company... Possible ten bags from here on just 100 machines....the prize is huge here if it all works out....I think there is a very good chance it will! All IMO dyor etc""